The FDA has added a Boxed Warning, its most prominent warning, to highlight the known risk of rare but serious liver injury associated with use of menopause medicine Veozah (fezolinetant). Learn more about the Veozah FDA update
Veozah Recall
The FDA has added a Boxed Warning, its most prominent warning, to highlight the known risk of rare but serious liver injury associated with use of menopause medicine Veozah (fezolinetant). Learn more about the Veozah FDA update